IL6 and neoplasm: Most antitumor therapies can induce inflammation by killing tumor cells and normal tissues, and in this process, the expression levels of multiple inflammatory cytokines, including IL-6, IL-8, TNF-α, and other inflammatory factors, are upregulated (94).